Cardiac resynchronization therapy defibrillator effectively managed arrhythmogenic left ventricular cardiomyopathy with dyssynchrony as supported by CMR findings.
Highlights the diagnostic value of CMR and supports CRT-D use in arrhythmogenic left ventricular cardiomyopathy with dyssynchrony.
Absolute Event Rate: 0% vs 0%
This case underscores the diagnostic value of CMR and supports the combined strategy of cardiac resynchronization therapy defibrillator in left ventricular-dominant disease with dyssynchrony, aligning with contemporary guidelines.
Cheng et al. (Fri,) reported a other. Cardiac resynchronization therapy defibrillator effectively managed arrhythmogenic left ventricular cardiomyopathy with dyssynchrony as supported by CMR findings.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: